The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma. - Karabekov A; Kemaikin V; Burkitbayev Z; Zhakhina G; Sipenova A; Berger I; Orumbayeva U; Iskakova Z; Ibragimova R; Temir N; Mamyr G; Kolesnikova O; et al. (Journal of clinical medicine, 2026)